Clinical trial

Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With…

NCT00249769 · PATH, Other · Completed

Key facts

NCT number NCT00249769
Title Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Official title Assessment of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine Given Alone
Lead sponsor PATH, Other
Collaborators Research Institute for Tropical Medicine, Manila, Philippines Quintiles, Inc. Industry Mahidol University
Status Completed
Phase Phase 3
Study type Interventional
Conditions Encephalitis, Japanese B
Intervention type Biological
Interventions Live Japanese encephalitis vaccine SA 14-14-2 (LJEV), Measles Vaccine (MV)
Enrollment 600
Start date Nov 21, 2005
Primary completion May 30, 2006
Completion May 30, 2006
First posted Nov 7, 2005
Last update posted Mar 10, 2020
Countries Philippines

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies